Literature DB >> 19382180

Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.

Maria V Barbolina1, Brian P Adley, David L Kelly, Jaclyn Shepard, Angela J Fought, Denise Scholtens, Peter Penzes, Lonnie D Shea, M Sharon Stack.   

Abstract

Epithelial ovarian carcinoma (EOC) is a leading cause of death from gynecologic malignancies, due mainly to the prevalence of undetected metastatic disease. The process of cell invasion during intraperitoneal anchoring of metastatic lesions requires concerted regulation of many processes, including modulation of adhesion to the extracellular matrix and localized invasion. Exploratory cDNA microarray analysis of early response genes (altered after 4 hr of 3D collagen culture) coupled with confirmatory real-time reverse-transcriptase polymerase chain reaction, multiple 3D cell culture matrices, Western blot, immunostaining, adhesion, migration and invasion assays were used to identify modulators of adhesion pertinent to EOC progression and metastasis. cDNA microarray analysis indicated a dramatic downregulation of connective tissue growth factor (CTGF) in EOC cells placed in invasion- mimicking conditions (3D Type I collagen). Examination of human EOC specimens revealed that CTGF expression was absent in 46% of the tested samples (n = 41), but was present in 100% of normal ovarian epithelium samples (n = 7). Reduced CTGF expression occurs in many types of cells and may be a general phenomenon displayed by cells encountering a 3D environment. CTGF levels were inversely correlated with invasion such that downregulation of CTGF increased, while its upregulation reduced collagen invasion. Cells adhered preferentially to a surface comprised of both collagen I and CTGF relative to either component alone using alpha6beta1 and alpha3beta1 integrins. Together these data suggest that downregulation of CTGF in EOC cells may be important for cell invasion through modulation of cell-matrix adhesion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19382180      PMCID: PMC2849282          DOI: 10.1002/ijc.24347

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  59 in total

Review 1.  Reciprocal interactions between adhesion receptor signaling and MMP regulation.

Authors:  H G Munshi; M S Stack
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

2.  A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells.

Authors:  R Gao; D R Brigstock
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

Review 3.  Connective tissue growth factor in the ovarian paracrine system.

Authors:  C R Harlow; Stephen G Hillier
Journal:  Mol Cell Endocrinol       Date:  2002-02-22       Impact factor: 4.102

4.  Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP.

Authors:  Juliane Heusinger-Ribeiro; Michael Eberlein; Nadia Abdel Wahab; Margarete Goppelt-Struebe
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

5.  Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).

Authors:  Angela Graness; Klaudia Giehl; Margarete Goppelt-Struebe
Journal:  Cell Signal       Date:  2005-06-20       Impact factor: 4.315

6.  Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.

Authors:  S M Ellerbroek; Y I Wu; C M Overall; M S Stack
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

Review 7.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

8.  Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin.

Authors:  T L Moser; S V Pizzo; L M Bafetti; D A Fishman; M S Stack
Journal:  Int J Cancer       Date:  1996-09-04       Impact factor: 7.396

9.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

10.  Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton.

Authors:  Christian Ott; Dominika Iwanciw; Angela Graness; Klaudia Giehl; Margarete Goppelt-Struebe
Journal:  J Biol Chem       Date:  2003-09-01       Impact factor: 5.157

View more
  16 in total

1.  Integrin regulation of beta-catenin signaling in ovarian carcinoma.

Authors:  Rebecca J Burkhalter; Jaime Symowicz; Laurie G Hudson; Cara J Gottardi; M Sharon Stack
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.

Authors:  Vanisri Raviraj; Hui Zhang; Hsin-ya Chien; Louise Cole; Erik W Thompson; Lilian Soon
Journal:  Clin Exp Metastasis       Date:  2012-01-22       Impact factor: 5.150

4.  Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.

Authors:  Matthew Dean; Vivian Jin; Angela Russo; Daniel D Lantvit; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

5.  Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma.

Authors:  Maria V Barbolina; Mijung Kim; Yueying Liu; Jaclyn Shepard; Abdelhak Belmadani; Richard J Miller; Lonnie D Shea; M Sharon Stack
Journal:  Mol Cancer Res       Date:  2010-05-11       Impact factor: 5.852

6.  Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Authors:  Maria V Barbolina; Yiuying Liu; Hilal Gurler; Mijung Kim; Andre A Kajdacsy-Balla; Lisa Rooper; Jaclyn Shepard; Michael Weiss; Lonnie D Shea; Peter Penzes; Matthew J Ravosa; M Sharon Stack
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

Review 7.  Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.

Authors:  Maria V Barbolina; Rebecca J Burkhalter; M Sharon Stack
Journal:  Biochem J       Date:  2011-07-01       Impact factor: 3.857

8.  DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

Authors:  Melissa J LaBonte; Peter M Wilson; William Fazzone; Susan Groshen; Heinz-Josef Lenz; Robert D Ladner
Journal:  BMC Med Genomics       Date:  2009-11-30       Impact factor: 3.063

9.  Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma.

Authors:  Yan Zhen; Yanfen Ye; Xiaoli Yu; Chunping Mai; Ying Zhou; Yan Chen; Huiling Yang; Xiaoming Lyu; Ye Song; Qiangyun Wu; Qiaofen Fu; Mengyang Zhao; Shengni Hua; Hao Wang; Zhen Liu; Yajie Zhang; Weiyi Fang
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.

Authors:  X Yu; Y Zhen; H Yang; H Wang; Y Zhou; E Wang; F M Marincola; C Mai; Y Chen; H Wei; Y Song; X Lyu; Y Ye; L Cai; Q Wu; M Zhao; S Hua; Q Fu; Y Zhang; K Yao; Z Liu; X Li; W Fang
Journal:  Cell Death Dis       Date:  2013-05-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.